Amesite's Revenue Surges 63% Amid Launch of AI Tool for Government Form Automation

Amesite shares surged over 100% after reporting a 63% revenue growth from its NurseMagic enterprise product and announcing a new AI tool to automate government form-filling. Enterprise sales have surpassed B2C sales, driven by rising demand from post-acute care providers. The new tool aims to address the government's increasing scrutiny of documentation and the looming HOPE requirement.

Amesite Inc. (NASDAQ: AMST) reported a significant 63% revenue growth from its NurseMagic™ enterprise product, with enterprise sales now surpassing B2C sales. This growth is driven by increasing demand from post-acute care providers seeking scalable, compliant technology to deliver full reimbursement rates. The company announced the launch of an AI-powered automated form fill tool to address the government's intensifying scrutiny of documentation and the upcoming Hospice Outcomes and Patient Evaluation (HOPE) requirement Amesite Reports 63% Revenue Growth from NurseMagic™ Enterprise; Announces Launch of AI-Powered Government Form-Fill Automation to Reduce Reporting Burden^[1].

The AI-powered HOPE automation solution within NurseMagic™ Enterprise is designed to enable organizations to auto-populate complex forms, cut administrative time, and assure full reimbursements. This comes as the Centers for Medicare & Medicaid Services (CMS) prepares to mandate the HOPE assessment this October, which is expected to significantly increase documentation burden per patient and strain hospice staffing.

"We’re no longer just selling to employees - we’re selling to serve every patient in the system and help organizations leverage AI technology as a true competitive advantage," said Brandon Owens, VP of Sales at Amesite. "That changes the game. The total addressable market is exponentially larger, and our pricing reflects the performance of our solution. Customers are choosing NurseMagic™ Enterprise to scale operations without adding staff, addressing one of the greatest costs in healthcare."

Amesite's CEO, Dr. Ann Marie Sastry, emphasized the company's unique approach to regulatory requirements, stating, "Our platform reimagines how post-acute care organizations handle regulatory requirements, enabling them to leverage our AI-powered tools to scale operations without adding staff. We specifically designed our solution to be an essential edge for customers, in a highly competitive, and demographically inevitable, market."

The post-acute care market is growing faster than the acute care market at a CAGR of 8%, indicating strong potential for growth in this segment. Amesite's NurseMagic™ platform has already been adopted by over 100 professions, serving B2B and B2C users across 50 states and 21 countries. The platform offers seamless integration into healthcare workflows and translations to over 50 languages, meeting HIPAA regulations while improving accuracy and efficiency.

Investors responded positively to the news, with Amesite shares surging over 100% following the announcement. The company's forward-looking statements indicate potential risks and uncertainties, including market competition and regulatory changes. However, the company's strong performance and innovative solutions suggest promising prospects for continued growth in the healthcare technology sector.

References:
Amesite Reports 63% Revenue Growth from NurseMagic™ Enterprise; Announces Launch of AI-Powered Government Form-Fill Automation to Reduce Reporting Burden^[1] "Amesite Reports 63% Revenue Growth from NurseMagic™ Enterprise; Announces Launch of AI-Powered Government Form-Fill Automation to Reduce Reporting Burden," The Manila Times, September 11, 2025.